TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
VCEL

Vericel Corp Ord

Healthcare · Biotechnology

40.00$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement VCEL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
60.1% 51.7% 52.1% 47.5% 35.4% 31.9% 32.2% 32.1% 33.2% 31.4% 27.4% 25.6%
39.9% 48.3% 47.9% 52.5% 64.6% 68.1% 67.8% 67.9% 66.8% 68.6% 72.6% 74.4%
73.8% 36.9% 28.1% 20.2% 15.0% 25.8% 10.5% 10.4% 12.1% 10.7% 10.5% 10.0%
47.8% 43.9% 50.4% 55.7% 53.9% 51.9% 55.4% 62.5% 65.0% 59.3% 60.2% 60.4%
121.7% 80.8% 78.5% 76.0% 68.9% 77.7% 65.9% 72.9% 77.2% 71.9% 70.6% 70.4%
-81.7% -32.6% -35.4% -23.4% -4.3% -9.5% 1.9% -5.0% -10.4% -3.3% 1.9% 4.0%
0.0% 0.0% 0.6% 1.7% 1.9% 0.0% 0.0% 0.0% 0.2% 0.3% 0.3% 0.6%
-69.2% -31.9% -36.0% -27.0% -9.0% -8.2% 2.5% -4.9% -9.7% -1.2% 4.4% 6.3%
-12.5% -0.5% 4.9% 1.7% 3.7% -1.5% 0.1% -0.1% 0.4% 0.4% 0.1% 0.3%
-69.2% -31.9% -36.0% -27.0% -9.0% -8.2% 2.3% -4.8% -10.2% -1.6% 4.4% 6.0%
-66.5% -28.8% -31.9% -22.8% -5.5% -6.7% 4.4% -3.0% -7.1% 1.5% 7.0% 11.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?